Moreover, KEGG pathway enrichment indicated anti-pancreatic cancer effects closely linked to the PI3K-Akt/mTOR signaling axis, one of the most frequently activated pathways in cancers, promoting cell survival, proliferation, and resistance to anticancer therapies44. This evidence concerns the gene PIK3CB and familial pancreatic carcinoma.